Author:
Escaliante Leonardo Augusto dos Santos,Busato Bianca,Petkowicz Carmen Lúcia de Oliveira,Cadena Silvia Maria Suter Correia,Noleto Guilhermina Rodrigues
Funder
Conselho Nacional de Desenvolvimento Científico e Tecnológico
Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
Subject
Molecular Biology,General Medicine,Biochemistry,Structural Biology
Reference58 articles.
1. A global view of hepatocellular carcinoma: trends, risk, prevention and management;Yang;Nat. Rev. Gastroenterol. Hepatol.,2019
2. Epidemiology and surveillance for hepatocellular carcinoma: new trends;Singal;J. Hepatol.,2020
3. Sorafenib in advanced hepatocellular carcinoma;Llovet;N. Engl. J. Med.,2008
4. Regorafenib for patients with hepatocellular carcinoma who progressed on sorafenib treatment (RESORCE): a randomised, double-blind, placebo-controlled, phase 3 trial;Bruix;Lancet,2017
5. A randomised phase 3 trial of Lenvatinib vs. Sorafenib in firstline treatment of patients with unresectable hepatocellular carcinoma;Kudo;Lancet,2018
Cited by
1 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献